The alliance with 4RMED (Link to 4RMED clinical section) to manage new INDs and clinical trials with collaborative work support pre-clinical testing expected to lead to new therapies:
- Acute pneumonia
- New anti-microbials vs. drug-resistant bacteria
- Pediatric necrotizing enterocolitis
- Oral and nasal vaccines